Please assess the completion status of the following clinical trial:

Trial Title: Use of QTRAC Technique to Measure Axonal Excitability in Anti-MAG Neuropathy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Anti-MAG neuropathy (peripheral neuropathy and IgM monoclonal gammopathy with anti-MAG activity superior to 1000 BTU)~Exclusion Criteria:~* current treatment with a medication that modifies peripheral nerve excitability (e.g. anticonvulsivants)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Patients (Type: EXPERIMENTAL): Patients suffering from anti-MAG neuropathy

Based on this trial design, predict the completion outcome and termination type (if applicable).